Compile Data Set for Download or QSAR
Report error Found 17 Enz. Inhib. hit(s) with Target = 'Inactive serine/threonine-protein kinase 19'
TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588065(US11542240, Formula number IV)
Affinity DataIC50: 24nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoPurchaseSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588081(US11542240, Formula number XLVI)
Affinity DataIC50: 29.3nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588083(US11542240, Formula number XLVIII)
Affinity DataIC50: 48.3nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588078(US11542240, Formula number XXXIX)
Affinity DataIC50: 57.1nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588080(US11542240, Formula number XLI)
Affinity DataIC50: 64.5nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588074(US11542240, Formula number XXX)
Affinity DataIC50: 70nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588082(US11542240, Formula number XLVII)
Affinity DataIC50: 79nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588077(US11542240, Formula number XXXVIII)
Affinity DataIC50: 79.9nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588072(US11542240, Formula number XX)
Affinity DataIC50: 90.9nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588079(US11542240, Formula number XL)
Affinity DataIC50: 96.7nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588073(US11542240, Formula number XXVII)
Affinity DataIC50: 98.8nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588076(US11542240, Formula number XXXVI)
Affinity DataIC50: 102nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588070(US11542240, Formula number XVII)
Affinity DataIC50: 127nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588075(US11542240, Formula number XXXIII)
Affinity DataIC50: 137nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588071(US11542240, Formula number XIX)
Affinity DataIC50: 148nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588069(US11542240, Formula number XVI)
Affinity DataIC50: 178nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent

TargetInactive serine/threonine-protein kinase 19(Human)
Trustees of Boston University

US Patent
LigandPNGBDBM588068(US11542240, Formula number V)
Affinity DataIC50: 252nMAssay Description:The optimal amount of STK19 is the minimal amount that produces luminescence within the linear portion of the kinase titration curve and generates an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
Go to US Patent